Gujarat Fluorochemicals (FLUOROCHEM) Q1 FY27 Profit Doubles as R32 Refrigerant Sales Surge 52%
A 52% jump in fluorochemical revenue, led by R32 refrigerant, drove a quarterly profit rebound, though margins remain below last year's peak.
Gujarat Fluorochemicals' Q1 profit more than doubled sequentially to ₹219 crore, powered by a 52% surge in its fluorochemicals business. The company is expanding R32 capacity and guiding for 17-20% annual fluoropolymer growth.
Gujarat Fluorochemicals entered FY27 with its core chemical segments firing on all cylinders. The company delivered a sharp rebound from a weak prior quarter, with profit more than doubling sequentially, as surging demand for its R32 refrigerant gas and a richer product mix in fluoropolymers drove broad-based growth.
The numbers show a strong recovery. Revenue rose 24% year-on-year to ₹1,588 crore, while profit grew 20% to ₹219 crore. The sequential jump is more dramatic: profit soared 101% from the ₹109 crore reported in Q4 FY26. This lifted the net profit margin to 13.8%, a significant recovery from 8.0% last quarter, though still 40 basis points below the margin in Q1 last year.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 1,588YoY +24% | 1,369 | 1,281 |
| Profit (₹ Cr) | 219YoY +20% | 109 | 182 |
| Net Profit Margin | 13.8%YoY -2.8% | 8.0% | 14.2% |
Why the profit engine roared back
The profit rebound was not a one-off but driven by two clear operational wins. First, the fluorochemicals segment, led by R32 refrigerant, was the standout. According to insights from DSIJ, revenue here surged 52% year-on-year to ₹458 crore. Management noted existing R32 capacity is fully utilized, with an expansion set for Q2 FY27.
Second, the larger fluoropolymers business grew a solid 15%, but more importantly, its mix improved. The company is shifting to higher-value specialty grades for semiconductors, data centers, and green hydrogen. This shift, rather than broad price hikes, is supporting realizations and margins.
The margin tension beneath growth
Despite the strong top line, the net profit margin dipped slightly compared to the same quarter last year. A flat consolidated EBITDA margin of 27%, reported by Investing.com, shows operating leverage has its limits. Higher employee and raw material costs absorbed some of the revenue gains.
Live Chart
· FLUOROCHEM
(BSE)
ISIN: INE09N301011
The company is navigating this with formula-based price passes to customers and a relentless focus on moving up the value chain. The strategy is to grow through volume and mix, not just price, which offers more sustainable defenses in a competitive global market.
How long can the run last?
Management's guidance suggests the momentum is built to continue. They reiterated an annual fluoropolymer growth target of 17-20%, driven by new customer approvals and capacity additions for high-end grades. The R32 capacity expansion due this quarter is expected to be fully utilized through 2027.
The larger, long-term story is battery materials. While still a small contributor, management expects revenue to reach a three-digit crore run-rate by Q4 FY27, with a significant ramp-up in FY28. This future growth vector is backed by a planned ₹2,300 crore capex in the segment for this year alone.
Key Points
- Consolidated profit more than doubled quarter-on-quarter to ₹219 crore, marking a strong sequential recovery.
- Growth was led by a 52% year-on-year surge in the fluorochemicals segment, primarily on robust R32 refrigerant sales.
- Fluoropolymer revenue grew 15%, supported by a shift to higher-value specialty products for advanced industries.
- The company is expanding R32 capacity, with commissioning expected in Q2 FY27, and guides for 17-20% annual fluoropolymer growth.
- A significant ₹2,300 crore is earmarked for battery materials capex in FY27, with commercial scaling expected from FY28.
Hexa Perspective
The quarter confirms Gujarat Fluorochemicals' core chemical business is on a firm recovery path, with R32 acting as a powerful near-term engine. The margin story, however, is one of stabilization rather than expansion, as costs keep pace with strong revenue growth.
The investment case now hinges on execution of the growth guide. The promised 17-20% fluoropolymer growth must materialize through the promised high-value mix, and the heavy battery materials capex must begin translating into meaningful revenue by next year. For now, the company is delivering on the near-term promises that matter most.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.